| Literature DB >> 33859798 |
Edward J Cochrane1, James Hulit2, Franz P Lagasse1, Tanguy Lechertier2, Brett Stevenson1, Corina Tudor2, Diana Trebicka2, Tim Sparey2, Andrew J Ratcliffe2.
Abstract
Some marketed antibiotics can cause mitochondria dysfunction via inhibition of the mitochondrial translation process. There is great interest in exploiting such effects within a cancer setting. To enhance accumulation of antibiotics within the mitochondria of cancer cells, and therefore delivery of a greater potency payload, a mitochondrial targeting group in the form of a triphenylphosphonium (TPP) cation was appended via an alkyl chain length consisting of 7 to 11 carbons to the ribosomal antibiotics azithromycin and doxycycline. Using MDA-MB-231 cells, the effects of each subseries on mitochondrial translation, mitochondrial bioenergetics, and cell viability are described.Entities:
Year: 2021 PMID: 33859798 PMCID: PMC8040039 DOI: 10.1021/acsmedchemlett.0c00632
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345